Arvinas

$76.14
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.87 (+2.52%) Today
$0.00 (0.00%) As of 9:00 PM UTC after-hours

Why Robinhood?

You can buy or sell Arvinas and other stocks, options, and ETFs commission-free!

About ARVN

Arvinas, Inc. Common Stock, also called Arvinas, is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Its lead products include ARV-110 and ARV-471. The company was founded in February 2013 and is headquartered in New Haven, CT. The listed name for ARVN is Arvinas, Inc. Common Stock.

CEO
John G. Houston
Employees
133
Headquarters
New Haven, Connecticut
Founded
2013
Market Cap
3.95B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
458.50K
High Today
$77.99
Low Today
$74.40
Open Price
$74.91
Volume
289.65K
52 Week High
$92.77
52 Week Low
$19.68

ARVN Earnings

-$0.79
-$0.46
-$0.12
$0.21
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, Pre-Market

You May Also Like

INSE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure